Catalyst Wire Dossier Catalyst Wire Dossier

Milvexian

milvexian · Janssen Pharmaceuticals
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Milvexian, covering 2023-08-21 to 2026-08-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE [Phase 3]

See pricing